Quality and Patient Safety


The Quality and Patient Safety Committee is committed to providing and promoting the dialogue around patient safety and quality improvement in order to best serve our patients and CAS members. The committee continues to support and establish initiatives which address patient safety concerns such as safe medication practices, workplace human factors, QI-methodology, and equal access to resources and learnings for all communities. The committee also continues to engage with other CAS Committees, and advises the CAS Board of Directors regarding patient safety and quality improvement matters.

What's New?

CAS has released a medication safety bulletin, with regards to the succinylcholine chloride shortage in Canada. Please download and share with your colleagues.

Date: November 17th, 2023
File Format: PDF


CAS Medication Shortage Bulletin: Succinylcholine Chloride
 

CAS has released a medication safety bulletin, with regards to the Sandoz Ketamine Hydrochloride shortages in Canada. Please download and share with your colleagues.

Date: February 24th, 2023
File Format: PDF


CAS Medication Shortage Bulletin - Ketamine Hydrochloride

The committee has released its latest safety bulletin, available in the March issue of the Anesthesia News newsletter. 

March 2023 - Equity: The Forgotten QI Element

 

If you have a question for the committee, please contact us.

Committee Members

  • Dr Conor Mc Donnell, Chair
  • Dr Gregory Dobson
  • Dr Claudia Paola Gomez, Physician Wellness Rep
  • Dr Esther Shin Hyun Kang
  • Dr Niveditha Karuppiah
  • Dr Maha Said Al Mandhari
  • Dr Kelly Mayson
  • Dr Dolores McKeen
  • Dr Kowe Olajide
  • Dr Melissa Setiawan
  • Dr Kevin Bach, Resident Representative
  • Dr Vanessa Sweet
  • Dr Mullein Thorleifson
  • Ms Cristina Mita